Direct-to-consumer (DTC) genetic testing has generated much concern due to nonstandardized products, unproven utility, and potential harm from testing results.1 Recommendations indicate that genetic testing should be US Food and Drug Administration (FDA)–approved, supported by predictive value and outcomes research, and offered only through qualified health care professionals.1